Clin2
NCT06573671Possibly a fitEnrolling by invitation

Histiocytosis in people who inject drugs

Histiocytosis

Part of Blood & lymphatic, Mental health clinical trials.

This trial looks at a condition called PVP-histiocytosis, which can happen in people who inject drugs made from tablets containing polyvinylpyrrolidone (PVP). The goal is to study these cases to better understand the condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 70 years
Study type
Observational

Who can take part

  • You are an adult (18 years or older).
  • You have a history of injecting drugs by dissolving tablets.
  • The tablets you injected contained a substance called polyvinylpyrrolidone (PVP).
  • You have been diagnosed with or are suspected to have PVP-histiocytosis.
  • You are not diagnosed with another type of histiocytosis based on tissue samples or medical history.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04665674Recruiting
Study of adults with pulmonary Langerhans cell histiocytosis

This study follows adults with a specific lung condition to better understand how it behaves over time. If you have the right diagnosis, joining could help researchers learn what to expect and how to manage it.

Paris
NCT05915208Recruiting
Follow-up study for people with histiocytic disorders

This study is checking in over time with people who have a histiocytic disorder. It may help doctors better understand how these conditions behave and what follow-up care works best.

Birmingham, Alabama
NCT07157683Not yet recruiting
Biomarker study for systemic histiocytosis

This trial aims to find biological markers in people with systemic histiocytosis by analyzing blood or tissue samples. It may help better understand and manage the disease.

Paris
NCT07339345Recruiting· Phase 2/Phase 3
Testing a combination therapy for hemophagocytic lymphohistiocytosis

This trial tests a new combination of medicines (the GO regimen) for people with hemophagocytic lymphohistiocytosis (HLH) that is either newly diagnosed, has come back, or hasn't responded to other treatments. It aims to see if this approach can help when a stem cell transplant isn't an option right now.

Beijing, Beijing Municipality
NCT06331377Recruiting
Study of blood cell disorders for patients 1 year and older

This study looks at people with histiocytic disorders, which are rare conditions where certain immune cells grow too much. It aims to learn more about these disorders to improve diagnosis and treatment.

Rochester, Minnesota
NCT06431945Recruiting
Hepatitis C testing for injection drug users

This trial offers free hepatitis C testing for people who inject or have injected drugs. The goal is to find hidden cases early so they can get treatment.

Brno

Hear when a new Histiocytosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.